Avantor, Inc. (AVTR) Q2 2026 Earnings Call Transcript
Avantor, Inc. (AVTR) Q2 2026 Earnings Call Transcript
Seeking Alpha7/29/2026Neutral
AVTR
Avantor IncNYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$8.48B
P/E Ratio
—
EPS
$-0.86
Beta
0.94
52W High
$15.93
52W Low
$7.26
50-Day MA
$9.79
200-Day MA
$10.22
Dividend Yield
—
Profit Margin
-8.42%
Forward P/E
13.70
PEG Ratio
—
About Avantor Inc
Avantor, Inc. provides products and services to clients in the biopharmaceutical, healthcare, education and government, advanced technologies and applied materials industries in America, Europe, Asia, the Middle East and Africa. The company is headquartered in Radnor, Pennsylvania.
Fundamentals
| Revenue (TTM) | $6.55B |
| Gross Profit (TTM) | $2.11B |
| EBITDA | $948.10M |
| Operating Margin | 6.26% |
| Return on Equity | -9.44% |
| Return on Assets | 2.78% |
| Revenue/Share (TTM) | $9.65 |
| Book Value | $8.26 |
| Price-to-Book | 1.40 |
| Price-to-Sales (TTM) | 1.23 |
| EV/Revenue | 1.732 |
| EV/EBITDA | 99.11 |
| Quarterly Earnings Growth (YoY) | -33.30% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $682.75M |
| Float | $664.28M |
| % Insiders | 1.49% |
| % Institutions | 102.77% |
Historical Volatility
HV 10-Day
44.06%
HV 20-Day
50.68%
HV 30-Day
46.25%
HV 60-Day
47.28%
HV Rank
45.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($10.44 target)
3
Buy11
Hold2
Sell1
Strong SellLatest News
Avantor (AVTR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Avantor (AVTR) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research7/29/2026Positive
Avantor, Inc. (AVTR) Beats Q2 Earnings and Revenue Estimates
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.24 per share a year ago.
Zacks Investment Research7/29/2026Positive
Avantor® Reports Second Quarter 2026 Results
Net sales of $1,692.3 million; increase of 0.5%; organic decline of 0.4% Net income of $38.1 million; Adjusted EBITDA of $254.3 million Diluted GAAP EPS of $0.06; adjusted EPS of $0.21 Operating cash flow of $178.2 million; free cash flow of $142.8 million Increases FY 2026 organic revenue growth and adjusted EPS guidance RADNOR, Pa., July 29, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, reports better than expected results for the second fiscal quarter of 2026.
PRNewsWire7/29/2026Neutral
Avantor, Inc. (AVTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Avantor (AVTR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Investment Research7/22/2026Positive
AVTR vs. ICLR: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Medical Services sector have probably already heard of Avantor, Inc. (AVTR) and Icon PLC (ICLR). But which of these two stocks is more attractive to value investors?
Zacks Investment Research7/21/2026Positive
Will Avantor (AVTR) Beat Estimates Again in Its Next Earnings Report?
Avantor (AVTR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks Investment Research7/15/2026Positive
Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership
AVTR's shares jump nearly 7% as NuSil expands its HIV prevention partnership for a three-month dapivirine vaginal ring.
Zacks Investment Research7/15/2026Positive
Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention Product
RADNOR, Pa., July 14, 2026 /PRNewswire/ -- Avantor (NYSE: AVTR), a leading global provider of mission-critical products and services to the life sciences and advanced technology industries, announced today the expansion of a collaboration between its NuSil® brand, a premier global manufacturer of high-purity silicones suitable for use in medical devices and drug-device combination products, and the Population Council, an international nonprofit research organization, to support the development of the Council's new three-month dapivirine vaginal ring for HIV prevention.
PRNewsWire7/14/2026Neutral
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.
Zacks Investment Research7/9/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AVTR and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 7/29/2026